Back
Molina Healthcare 10K Form
Buy
59
MOH
Molina Healthcare
Last Price:
310.53
Seasonality Move:
3.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-07-31 | 10Q | MOH/Molina Healthcare Quarterly |
| 2020-05-01 | 10Q | MOH/Molina Healthcare Quarterly |
| 2020-02-14 | 10K | MOH/Molina Healthcare Annual |
| 2019-10-30 | 10Q | MOH/Molina Healthcare Quarterly |
| 2019-07-31 | 10Q | MOH/Molina Healthcare Quarterly |
| 2019-04-30 | 10Q | MOH/Molina Healthcare Quarterly |
Receive MOH News And Ratings
See the #1 stock for the next 7 days that we like better than MOH
MOH Financial Statistics
Sales & Book Value
| Annual Sales: | $31.97B |
|---|---|
| Cash Flow: | $456M |
| Price / Cash Flow: | 13.53 |
| Annual Sales: | $62.43 |
| Price / Book: | 5 |
Profitability
| EPS (TTM): | 15.78000 |
|---|---|
| Net Income (TTM): | $916M |
| Gross Margin: | $3.93B |
| Return on Equity: | 29.09% |
| Return on Assets: | 7.08% |
Molina Healthcare Earnings Forecast
Key Molina Healthcare Financial Ratios
- The Gross Profit Margin over the past 22 years for MOH is 12.28%.
- The Selling, General & Administrative Expenses for MOH have been equal to 7.23% of Gross Profit Margin.
- The Interest Expense is 13.89% of Operating Income.
- The Net Earning history of MOH is 2.48% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 16 years.
Molina Healthcare Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Healthcare Plans |
| Sector: | Healthcare |
| Current Symbol: | MOH |
| CUSIP: | 60855R |
| Website: | molinahealthcare.com |
Debt
| Debt-to-Equity Ratio: | 0.6 |
|---|---|
| Current Ratio: | 1.52 |
| Quick Ratio: | 1.48 |
Price-to-Earnings
| Trailing P/E Ratio: | 22.91 |
|---|---|
| Forward P/E Ratio: | 13.41 |
MOH Technical Analysis vs Fundamental Analysis
Buy
59
Molina Healthcare (MOH)
is a Buy
Is Molina Healthcare a Buy or a Sell?
-
Molina Healthcare stock is rated a Buy
The current Molina Healthcare [MOH] share price is $310.44. The Score for MOH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.